amphotericin b

amphotericin b is a lipid of Polyketides (PK) class. Amphotericin b often locates in Mitochondria.

Cross Reference

Introduction

To understand associated biological information of amphotericin b, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with amphotericin b

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with amphotericin b?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What lipids are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What genes are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with amphotericin b

Download all related citations
Per page 10 20 50 100 | Total 10373
Authors Title Published Journal PubMed Link
pmid:24852901
pmid:24850753
pmid:29485004
pmid:
Kagan L et al. Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data. 2011 AAPS J pmid:21431453
Baas B et al. Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form. 1999 AAPS PharmSci pmid:11741206
Darole PS et al. Formulation and evaluation of microemulsion based delivery system for amphotericin B. 2008 AAPS PharmSciTech pmid:18446472
Kaur L et al. A Mechanistic Study to Determine the Structural Similarities Between Artificial Membrane Strat-Mâ„¢ and Biological Membranes and Its Application to Carry Out Skin Permeation Study of Amphotericin B Nanoformulations. 2018 AAPS PharmSciTech pmid:29488196
Adhikari K et al. Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation. 2016 AAPS PharmSciTech pmid:26349688
Patere SN et al. Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis. 2017 AAPS PharmSciTech pmid:27222025